Loading... Please wait...
Contact Us
Would you like more
information on this report
Please contact us today at +44(0)20.7665.9240
or +1 212.220.0880
or write to us.

Multiple Sclerosis: Update Bulletin [June 2014]

Product Code:
596200269
Release Date:
June 2014
Format:
PDF
Price:
£1,140

Gain new KOL insights on the latest events happening in Multiple Sclerosis: CHMP recommends EU label expansion of Novartis' Gilenya

Highlights from this event update bulletin

  • CHMP recommends EU label expansion of Novartis' Gilenya
  • Teva’s defence strategies for Copaxone continue to hold
  • Plegridy moves one step closer to launch
  • Decision on Lemtrada filing in the US by Q4
  • Teva and Active Biotech to continue with the development of Nerventra

Update Bulletins include expert insight and analysis based on FirstWord analyst re-engagement with the KOLs after major events such as product approvals, key data releases and major conferences to deliver the most valuable insights with each update.




customer.service@firstwordpharma.com

All Contents Copyright © 2019 Doctor's Guide Publishing Limited All Rights Reserved